COVID-19: Antibodies may last for days in some, decades in others - Study

The research, published in The Lancet Microbe journal, noted that recovered patients with low levels of neutralising antibodies may still be protected from reinfection if they have robust immunity

Antibodies against the novel Coronavirus wane at different rates, lasting for mere days in some individuals, while persisting in others for decades, according to a new study which says COVID-19 severity could be a deciding factor in having longer-lasting protection against reinfection.

The research, published in The Lancet Microbe journal, noted that recovered patients with low levels of neutralising antibodies may still be protected from reinfection if they have robust immunity in the form of the body’s T cells.

In the study, scientists, including those from Duke-NUS Medical School in Singapore, followed 164 COVID-19 patients for six to nine months, analysing their blood for neutralising antibodies against the SARS-CoV-2 virus, their T cells and immune system signalling molecules. 

They then used this information to train a machine learning algorithm to predict the trajectories of people’s neutralising antibodies over time. Based on the analysis, the researchers categorised people into five groups depending on how long their antibodies lasted. 

“The key message from this study is that the longevity of functional neutralising antibodies against SARS-CoV-2 can vary greatly and it is important to monitor this at an individual level,” said Professor Wang Linfa, from Duke-NUS’ Emerging Infectious Diseases (EID) Programme, a corresponding author of the study.

HK suspends use of Pfizer over bottle lids
Hong Kong suspended use of the Pfizer vaccine on Wednesday after its Chinese distributor informed the city that one batch had defective bottle lids. The city’s government said the suspension was immediate while the matter is being investigated by distributor Fosun Pharma and BioNTech.

China administers over 80.4 mn doses
More than 80.4 million doses of COVID-19 vaccines had been administered across China as of March 22, according to the figures released by the State Council’s COVID-19 response inter-agency task force. The country’s inoculated population has seen steady growth, Xinhua news agency reported.

Netherlands under lockdown till Apr 20
The COVID-19 lockdown in the Netherlands will be extended to April 20 due to the increasing numbers of infections and hospital admissions, Prime Minister Mark Rutte has said. “The number of Corona patients in intensive care is increasing. The third wave is starting to become visible,” Rutte said.

Vaccination is a national priority: Macron
French President Emmanuel Macron has stressed on the importance of vaccination as the country’s COVID-19 cases kept rising. “Vaccination is a national priority,” Macron told reporters on Tuesday during a visit to a vaccination centre in Valenciennes, northern France, Xinhua news agency reported. The president said vaccination would be rolled out during public holidays and weekends.

3,93,531
No. of new cases reported globally in the past 24 hours

12,43,39,436
Total no. of cases worldwide

27,36,668
Total no. of deaths worldwide

Source: WHO/Johns Hopkins

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!